ProfileGDS5678 / 1455471_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 21% 21% 21% 20% 20% 23% 22% 20% 20% 20% 20% 20% 21% 20% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.5270221
GSM967853U87-EV human glioblastoma xenograft - Control 22.4873121
GSM967854U87-EV human glioblastoma xenograft - Control 32.4960921
GSM967855U87-EV human glioblastoma xenograft - Control 42.4264120
GSM967856U87-EV human glioblastoma xenograft - Control 52.4337720
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.5990823
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.5580822
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.4632320
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.4498820
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.4744520
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.4738220
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.4541920
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.4888721
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.4771520